Argent Biopharma (ASX:RGT) FCF Yield % : -87.80 (As of Jun. 04, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Argent Biopharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Argent Biopharma's Trailing 12-Month Free Cash Flow is A$-13.12 Mil, and Market Cap is A$14.94 Mil. Therefore, Argent Biopharma's FCF Yield % for today is -87.80%.

The historical rank and industry rank for Argent Biopharma's FCF Yield % or its related term are showing as below:

ASX:RGT' s FCF Yield % Range Over the Past 10 Years
Min: -1234.24 Med: -19.97 Max: -5.21
Current: -87.8

During the past 13 years, the highest FCF Yield % of Argent Biopharma was -5.21%. The lowest was -1234.24%. And the median was -19.97%.

ASX:RGT's FCF Yield % is ranked worse than
95.1% of 1082 companies
in the Drug Manufacturers industry
Industry Median: -0.195 vs ASX:RGT: -87.80

Argent Biopharma's FCF Margin % for the quarter that ended in Dec. 2023 was -840.19%.

Argent Biopharma FCF Yield % Historical Data

The historical data trend for Argent Biopharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argent Biopharma FCF Yield % Chart

Argent Biopharma Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Yield %

Get a 7-Day Free Trial

-10.64

-34.65

-17.85

-34.02

-70.62

Argent Biopharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-15.55	-32.47	-44.35	-60.22	-91.42

Competitive Comparison of Argent Biopharma's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Argent Biopharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Argent Biopharma's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Argent Biopharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Argent Biopharma's FCF Yield % falls into.

Argent Biopharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Argent Biopharma's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-12.185	/	17.25345
	=	-70.62%

Argent Biopharma's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-7.923	*	2	/	17.33351
	=	-91.42%

Argent Biopharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Argent Biopharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Argent Biopharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Argent Biopharma (ASX:RGT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Argent Biopharma Ltd (ASX:RGT) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

MGCLF:USA MXC:UK H5O:Germany

Address

295 Rokeby Road, Suite 1, Subiaco, WA, AUS, 6008

Website

https://mgcpharma.co.uk

MGC Pharmaceuticals Ltd is a biopharma company with a Nature to Medicine strategy at the forefront of the emerging phytocannabinoid and plant-derived medicine markets. The company's mission is to build an innovative, global bio-pharma company providing standardized, affordable plant-derived medicines of the highest regulatory compliance for targeted global markets.